Data for analysis of implementability of Pharmacogenomics in 8 African countries with ML# rated National Regulatory Authorities- based on registered drug formulation/strength availability as of 1 June 2025. These countries include Egypt, Ghana, Nigeria, Rwanda, Senegal, South Africa, Tanzania, and Zimbabwe.